UBS Group’s Conformis, Inc. Common Stock CFMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-120,914
| Closed | -$265K | – | 10379 |
|
|
2023
Q2 | $265K | Buy |
120,914
+5,083
| +4% | +$7.22K | ﹤0.01% | 5285 |
|
|
2023
Q1 | $186K | Buy |
115,831
+22,911
| +25% | +$49.3K | ﹤0.01% | 5434 |
|
|
2022
Q4 | $308K | Buy |
92,920
+30,842
| +50% | +$95.7K | ﹤0.01% | 5098 |
|
|
2022
Q3 | $296K | Sell |
62,078
-4,684
| -7% | -$32.5K | ﹤0.01% | 4780 |
|
|
2022
Q2 | $591K | Buy |
66,762
+1,030
| +2% | +$11.8K | ﹤0.01% | 4137 |
|
|
2022
Q1 | $1.02M | Sell |
65,732
-3,265
| -5% | -$53.7K | ﹤0.01% | 4077 |
|
|
2021
Q4 | $1.31M | Sell |
68,997
-4,121
| -6% | -$106K | ﹤0.01% | 4149 |
|
|
2021
Q3 | $2.43M | Buy |
73,118
+1,342
| +2% | +$47.3K | ﹤0.01% | 3412 |
|
|
2021
Q2 | $2.06M | Buy |
71,776
+13,243
| +23% | +$313K | ﹤0.01% | 3551 |
|
|
2021
Q1 | $1.45M | Buy |
58,533
+19,054
| +48% | +$514K | ﹤0.01% | 3879 |
|
|
2020
Q4 | $652K | Buy |
39,479
+7,386
| +23% | +$127K | ﹤0.01% | 4377 |
|
|
2020
Q3 | $672K | Buy |
32,093
+6,435
| +25% | +$123K | ﹤0.01% | 3948 |
|
|
2020
Q2 | $526K | Sell |
25,658
-1,418
| -5% | -$29.6K | ﹤0.01% | 4086 |
|
|
2020
Q1 | $427K | Sell |
27,076
-5,591
| -17% | -$137K | ﹤0.01% | 4111 |
|
|
2019
Q4 | $1.23M | Buy |
32,667
+2,887
| +10% | +$137K | ﹤0.01% | 4016 |
|
|
2019
Q3 | $1.38M | Buy |
29,780
+2,318
| +8% | +$139K | ﹤0.01% | 3666 |
|
|
2019
Q2 | $2.99M | Buy |
27,462
+2,082
| +8% | +$171K | ﹤0.01% | 2788 |
|
|
2019
Q1 | $1.83M | Buy |
25,380
+13,318
| +110% | +$380K | ﹤0.01% | 3061 |
|
|
2018
Q4 | $108K | Sell |
12,062
-596
| -5% | -$10K | ﹤0.01% | 5471 |
|
|
2018
Q3 | $335K | Buy |
12,658
+6,060
| +92% | +$165K | ﹤0.01% | 4681 |
|
|
2018
Q2 | $206K | Sell |
6,598
-900
| -12% | -$31.1K | ﹤0.01% | 4921 |
|
|
2018
Q1 | $272K | Sell |
7,498
-1,336
| -15% | -$56.1K | ﹤0.01% | 4575 |
|
|
2017
Q4 | $526K | Sell |
8,834
-1,627
| -16% | -$130K | ﹤0.01% | 4257 |
|
|
2017
Q3 | $920K | Buy |
10,461
+489
| +5% | +$48.4K | ﹤0.01% | 3778 |
|
|
2017
Q2 | $1.07M | Sell |
9,972
-810
| -8% | -$97.3K | ﹤0.01% | 3562 |
|
|
2017
Q1 | $1.41M | Buy |
10,782
+3,733
| +53% | +$632K | ﹤0.01% | 3247 |
|
|
2016
Q4 | $1.43M | Buy |
7,049
+309
| +5% | +$68.4K | ﹤0.01% | 3230 |
|
|
2016
Q3 | $1.67M | Buy |
6,740
+1,976
| +41% | +$397K | ﹤0.01% | 3005 |
|
|
2016
Q2 | $836K | Buy |
4,764
+4,187
| +726% | +$984K | ﹤0.01% | 3534 |
|
|
2016
Q1 | $155K | Buy |
577
+166
| +40% | +$43.9K | ﹤0.01% | 4677 |
|
|
2015
Q4 | $178K | Sell |
411
-1,240
| -75% | -$623K | ﹤0.01% | 4768 |
|
|
2015
Q3 | $746K | Buy |
+1,651
| New | +$831K | ﹤0.01% | 3597 |
|
Other funds holding CFMS
UBS Group's CFMS Position: Q3 2023 in Review
UBS Group sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2023, closing a stake of 120,914 shares — an estimated $265K sold.
UBS Group first reported a position in CFMS in Q3 2015 and held it in 32 quarters. The position peaked at $2.99M in Q2 2019. 1 fund tracked by Wall St. Rank holds CFMS as of Q3 2023.
- UBS Group reported no remaining Conformis, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- UBS Group sold 120,914 Conformis, Inc. Common Stock shares in Q3 2023, an estimated $265K.
- UBS Group first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 32 quarters.
- UBS Group's Conformis, Inc. Common Stock position peaked at $2.99M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2023.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.